Oral, once-daily roflumilast and its active N-oxide metabolite exhibit dose-proportional pharmacokinetics between 250mg and 500mg

被引：0
|
作者：
Huennemeyer, A [1 ]
Zech, K [1 ]
Bethke, TD [1 ]
Boehmer, G [1 ]
Gleiter, CH [1 ]
机构：
[1] ALTANA Pharma AG, Constance, Germany
来源：
CHEST | 2004年 / 126卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：804S / 805S
页数：2
相关论文
共 6 条
  • [1] Roflumilast, a once-daily, oral PDE4 inhibitor and its active metabolite roflumilast N-oxide show pharmacokinetic dose proportionality in healthy subjects
    Böhmer, GM
    Hauns, B
    David, M
    Fux, R
    Gleiter, CH
    Hermann, R
    Zech, K
    Bethke, TD
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2004, 369 : R148 - R148
  • [2] Dose-proportional intraindividual single-and repeated-dose pharmacokinetics of roflumilast, an oral, once-daily phosphodiesterase 4 inhibitor
    Bethke, Thomas D.
    Boehmer, Gabriele M.
    Hermann, Robert
    Hauns, Bernhard
    Fux, Richard
    Moerike, Klaus
    David, Michael
    Knoerzer, Dietrich
    Wurst, Wilhelm
    Gleiter, Christoph H.
    JOURNAL OF CLINICAL PHARMACOLOGY, 2007, 47 (01): : 26 - 36
  • [3] Pharmacokinetics of Roflumilast and Its Active Metabolite Roflumilast N-Oxide in Healthy Chinese Subjects After Single and Multiple Oral Doses
    Qian Li
    Yiya Wang
    Lingye Liu
    Pengcheng Ma
    Li Ding
    European Journal of Drug Metabolism and Pharmacokinetics, 2017, 42 : 371 - 381
  • [4] Pharmacokinetics of Roflumilast and Its Active Metabolite Roflumilast N-Oxide in Healthy Chinese Subjects After Single and Multiple Oral Doses
    Li, Qian
    Wang, Yiya
    Liu, Lingye
    Ma, Pengcheng
    Ding, Li
    EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 2017, 42 (03) : 371 - 381
  • [5] Effects of roflumilast N-oxide, the active metabolite of the oral, once-daily PDE4 inhibitor roflumilast, on human cells involved in chronic obstructive pulmonary disease in vitro
    Beume, R.
    Tenor, H.
    Schudt, C.
    Morcillo, E. J.
    Cortijo, J.
    Hatzelmann, A.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2010, 381 : 89 - 89
  • [6] A Single-center, Open-label, Parallel Control Study Comparing the Pharmacokinetics and Safety of a Single Oral Dose of Roflumilast and Its Active Metabolite Roflumilast N-oxide in Healthy Chinese and Caucasian Volunteers
    Han, Mai
    Lin, Xiao-Yan
    Cui, Gang
    Chen, Shuai
    Wu, Wei
    Mi, Na
    Wang, Jing
    Xiao, Chun-Yan
    Zhang, Xin
    Lu, Xing
    Li, Jin-Tong
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2023, 12 (03): : 314 - 323
1